1. Home
  2. NTR vs ONC Comparison

NTR vs ONC Comparison

Compare NTR & ONC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nutrien Ltd.

NTR

Nutrien Ltd.

HOLD

Current Price

$62.64

Market Cap

26.6B

Sector

Industrials

ML Signal

HOLD

ONC

BeiGene Ltd. American Depositary Shares

HOLD

Current Price

$319.15

Market Cap

34.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NTR
ONC
Founded
2017
2010
Country
Canada
Switzerland
Employees
N/A
N/A
Industry
Agricultural Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
26.6B
34.8B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
NTR
ONC
Price
$62.64
$319.15
Analyst Decision
Hold
Strong Buy
Analyst Count
17
12
Target Price
$63.76
$369.50
AVG Volume (30 Days)
2.6M
279.4K
Earning Date
11-05-2025
11-06-2025
Dividend Yield
3.47%
N/A
EPS Growth
150.34
N/A
EPS
3.70
0.58
Revenue
$25,671,000,000.00
$4,972,687,000.00
Revenue This Year
$6.44
$895.40
Revenue Next Year
$1.26
$22.04
P/E Ratio
$16.98
$514.97
Revenue Growth
0.45
50.43
52 Week Low
$43.70
$170.99
52 Week High
$65.08
$385.22

Technical Indicators

Market Signals
Indicator
NTR
ONC
Relative Strength Index (RSI) 66.29 41.76
Support Level $58.04 $315.50
Resistance Level $61.42 $326.77
Average True Range (ATR) 1.28 11.23
MACD 0.35 -3.05
Stochastic Oscillator 98.22 18.85

Price Performance

Historical Comparison
NTR
ONC

About NTR Nutrien Ltd.

Created in 2018 as a result of the merger between PotashCorp and Agrium, Nutrien is the world's largest fertilizer producer by capacity. Nutrien produces the three main crop nutrients—nitrogen, potash, and phosphate—although its main focus is potash, where it is the global leader in installed capacity with a roughly 20% market share. The company is also the largest agricultural retailer in North America and Australia, selling fertilizers, crop chemicals, seeds, and services directly to farm customers through its brick-and-mortar stores and online platforms.

About ONC BeiGene Ltd. American Depositary Shares

Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeOne is a commercial-stage biotechnology company with global sales. It focuses on oncology therapeutics and differentiates itself from other companies with a contract research organization-free, or CRO-free strategy. BeOne runs global clinical trials with its own team. As of 2024, its core drug is Brukinsa, a small molecule drug for various blood cancers that makes up more than 60% of BeOne's revenue.

Share on Social Networks: